Novartis Recalls 4 Way Nasal Spray Due to Illegible Labeling
Novartis Consumer Health is recalling 4 Way Nasal Spray because lot numbers and expiration dates may be illegible.
The agency’s classification
FDA (Drugs): Class III
Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 1/5 (Low).
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The recall is classified as FDA Class III, which is defined as unlikely to cause adverse health consequences. The issue is limited to packaging and labeling legibility.
Plain-English summary
Novartis Consumer Health is voluntarily recalling 4 Way Nasal Decongestant Fast Acting Nasal Spray. The recall is due to labeling issues where the lot number and/or expiration date may be illegible.
The affected product is an over-the-counter nasal spray containing phenylephrine hydrochloride 1%. It is distributed in 1/2-fl. oz., 1-fl. oz., and 1.25-fl. oz. bottles. The recall covers units distributed nationwide and in Panama.
Consumers with affected products should stop using them and contact Novartis Consumer Health for a refund or replacement. The specific lot numbers and expiration dates are listed in the official recall notice.
The recalled product
- Product
- 4 WAY (PHENYLEPHRINE HYDROCHLORIDE)
- Brand
- 4 WAY
- Manufacturer
- Novartis Consumer Health
- Category
- Drug — OTC Nasal Spray
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot #: a) 10108375
- 10108376
- 10110025
- 10110026
- 10115487
- 10115488
- 10120594
- 10120595
- 10120596
- 10120597
- 10120753
- 10120754
- 10120755
- 10127564
- and 10127567
- Exp 4/13 to 11/13
- b) 10107916
- 10108368
- 10108369
- 10108370
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 5 recalled by Novartis Consumer Health under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 5 products in this recall →Related recalls
Same manufacturer · Novartis Consumer Health
See all →- ModerateNovartis Recalls Benefiber Fiber Supplement Stick Packs Due to Consumer Complaints
FDA (Food) · 2014-03-05
- ModerateNovartis Recalls Theraflu Severe Cold & Cough Powder Packets for Foreign Substances
FDA (Drugs) · 2014-01-29
- HighNovartis Recalls Theraflu Powder Packets Due to Foreign Substance Presence
FDA (Drugs) · 2014-01-29
- ModerateNovartis Recalls NeoCitran Extra Strength Powder Packets Due to Foreign Substances
FDA (Drugs) · 2014-01-29
- ModerateNovartis Recalls Theraflu Exte Powder Packets Due to Foreign Substances
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-10-14
- HighJ K Patisserie Chocolate Chip Cookies Recalled for Undeclared Soy
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- LowMindray ePM Series Patient Monitor Manuals Recalled for Alarm Clarification
FDA (Devices) · 2026-10-14
Similar recalls
- ModerateFDA Recalls NaturalCare bioAllers Nasal Spray Due to Manufacturing Defects
FDA (Drugs) · 2023-03-15
- ModerateRhinall Nasal Decongestant Spray Recalled for Manufacturing Quality Deviations
FDA (Drugs) · 2018-10-24
- ModerateFDA Recalls Best Choice Nasal Spray Due to Manufacturing Quality Issues
FDA (Drugs) · 2018-10-24
- ModerateFDA Recalls Premier Value Nasal Spray Due to Manufacturing Deviations
FDA (Drugs) · 2018-10-24
- ModerateFDA Recalls Premier Value Nasal Decongestant Spray Due to Quality Concerns
FDA (Drugs) · 2018-10-24
- LowNovartis Recalls Maalox Nighttime Antacid Tablets Due to Illegible Labeling
FDA (Drugs) · 2013-08-28